NeuBase Therapeutics SG&A Expense (Quarterly) Analysis

NeuBase Therapeutics Inc (NBSE)

0.416 0.00 (0.00%) USD | NASDAQ | May 01, 16:00

0.395 -0.02 (-5.05%) After-Hours: 07:46

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2004. Upgrade now.

Date	Value
September 30, 2023	1.203M
June 30, 2023	2.404M
March 31, 2023	2.917M
December 31, 2022	2.596M
September 30, 2022	2.236M
June 30, 2022	3.604M
March 31, 2022	3.094M
December 31, 2021	2.936M
September 30, 2021	3.369M
June 30, 2021	3.470M
March 31, 2021	2.722M
December 31, 2020	2.642M
September 30, 2020	2.498M
June 30, 2020	2.331M
March 31, 2020	2.739M
December 31, 2019	2.555M
September 30, 2019	6.632M
June 30, 2019	0.8885M
March 31, 2019	0.8944M
December 31, 2018	0.681M
September 30, 2018	0.6986M
June 30, 2018	0.8347M
March 31, 2018	0.5912M
December 31, 2017	1.51M
September 30, 2017	0.7236M

Date	Value
June 30, 2017	1.404M
March 31, 2017	1.404M
December 31, 2016	1.746M
September 30, 2016	1.807M
June 30, 2016	1.665M
March 31, 2016	2.966M
December 31, 2015	1.218M
September 30, 2015	1.803M
June 30, 2015	1.555M
March 31, 2015	3.335M
December 31, 2014	0.8125M
September 30, 2014	1.534M
June 30, 2014	0.7859M
March 31, 2014	1.338M
December 31, 2013	0.6691M
September 30, 2013	0.386M
June 30, 2013	0.9193M
March 31, 2013	0.2344M
December 31, 2012	0.2362M
September 30, 2012	0.6617M
June 30, 2012	0.2817M
March 31, 2012	0.5563M
December 31, 2011	0.161M
September 30, 2011	0.2917M
June 30, 2011	0.1806M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.8885M

Minimum

Jun 2019

6.632M

Maximum

Sep 2019

2.824M

Average

2.682M

Median

SG&A Expense (Quarterly) Benchmarks